Consensus Tarsus Pharmaceuticals, Inc.

Equities

TARS

US87650L1035

Market Closed - Nasdaq Other stock markets 04:00:00 2024-05-20 pm EDT			5-day change	1st Jan Change
38.73 ^USD	+1.28%		+0.94%	+91.26%

May. 15	Transcript : Tarsus Pharmaceuticals, Inc. Presents at Bank of America Health Care Conference 2024, May-15-2024 01:55 PM
May. 09	Oppenheimer Adjusts Tarsus Pharmaceuticals Price Target to $61 From $59, Maintains Outperform Rating	MT

Evolution of the average Target Price on Tarsus Pharmaceuticals, Inc.

Price target over the last 5 years

History of analyst recommendation changes

8088857c9390f.rKclSbwmW7cv5gTEps8lFg4YzFy9FvH0Gr6sR_d0oHc.3NAIfo1hLPVGgm68yodIbzlfljDqI4iNXunzKcEi5ziZ4REnhFIp2EGkUQ~53960c859e368bc072ee0323c15870ac

Analyst Recommendations on Tarsus Pharmaceuticals, Inc.

Oppenheimer Adjusts Tarsus Pharmaceuticals Price Target to $61 From $59, Maintains Outperform Rating	May. 09	MT
Goldman Sachs Adjusts Price Target on Tarsus Pharmaceuticals to $30 From $19, Maintains Neutral Rating	Feb. 29	MT
Oppenheimer Raises Tarsus Pharmaceuticals Price Target to $59 From $55, Maintains Outperform Rating	Feb. 28	MT
Goldman Sachs Starts Tarsus Pharmaceuticals With Neutral Rating, $19 Price Target	Nov. 20	MT
HC Wainwright Adjusts Price Target on Tarsus Pharmaceuticals to $50 From $42, Keeps Buy Rating	Nov. 10	MT
Guggenheim Raises Price Target on Tarsus Pharmaceuticals to $49 From $46, Maintains Buy Rating	23-09-11	MT
HC Wainwright Adjusts Tarsus Pharmaceuticals Price Target to $42 From $50, Maintains Buy Rating	23-08-11	MT
HC Wainwright Adjusts Price Target on Tarsus Pharmaceuticals to $50 From $44, Maintains Buy Rating	23-07-26	MT
William Blair Initiates Tarsus Pharmaceuticals at Outperform Rating	23-07-18	MT
HC Wainwright Adjusts Price Target on Tarsus Pharmaceuticals to $44 From $40, Keeps Buy Rating	23-06-26	MT
Guggenheim Raises Price Target on Tarsus Pharmaceuticals to $42 From $40, Maintains Buy Rating	23-06-16	MT
Guggenheim Initiates Coverage on Tarsus Pharmaceuticals With Buy Rating, $40 Price Target	23-05-18	MT
Oppenheimer Adjusts Tarsus Pharmaceuticals Price Target to $43 From $66, Maintains Outperform Rating	22-11-10	MT
Barclays Starts Tarsus Pharmaceuticals at Overweight With $40 Price Target	22-08-01	MT
Oppenheimer Adjusts Price Target on Tarsus Pharmaceuticals to $66 From $55, Keeps Outperform Rating	22-05-03	MT
HC Wainwright Starts Tarsus Pharmaceuticals at Buy With $40 Price Target	21-12-21	MT
Oppenheimer Initiates Coverage on Tarsus Pharmaceuticals With Outperform Rating, $55 Price Target	21-11-23	MT
TARSUS PHARMACEUTICALS : Raymond James Adjusts Tarsus Pharmaceuticals' Price Target to $65 from $50, Keeps Strong Buy Rating	21-10-08	MT
TARSUS PHARMACEUTICALS : Raymond James Adjusts Tarsus Pharmaceuticals' Price Target to $50 From $39, Maintains Strong Buy Rating	21-06-29	MT
TARSUS PHARMACEUTICALS : Jefferies Adjusts Price Target on Tarsus Pharmaceuticals to $45 From $35, Reiterates Buy Rating	21-06-22	MT
TARSUS PHARMACEUTICALS : Raymond James Starts Tarsus Pharmaceuticals at Strong Buy with $39 Price Target	20-11-10	MT
TARSUS PHARMACEUTICALS : BofA Securities Starts Tarsus Pharmaceuticals at Buy With $33 Price Target	20-11-10	MT
TARSUS PHARMACEUTICALS : Ladenburg Thalmann Starts Tarsus Pharmaceuticals at Buy With $42 Price Target	20-11-10	MT
TARSUS PHARMACEUTICALS : Jefferies & Co Initiates Coverage on Tarsus Pharmaceuticals With Buy Rating, $35 Price Target	20-11-10	MT